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Objective. To investigate the postpartum morbidity and postpartum management of febrile morbidity associated with advanced
HIV infection. Methods. A case control study of HIV infected women at a tertiary care center during January 2000–June 2005 was
performed. Postpartum morbidity was deﬁned as endometritis, blood transfusion, wound complication, readmission, infectious
morbidity, or unexpected surgery. Results. Women in Group 1 had AIDS (N = 33), Group 2 were relatively immunocompetent
HIV infected women (N = 115), and Group 3 were uninfected women (N = 152). Group 1 was more likely to have a postpartum
morbidity (32.3 versus 19.3 and 13.2%, P = .03) and to have postpartum imaging 18.8 versus 7.9 and 2.6%, P = .002. After
controlling for potential confounders, cesarean delivery (OR 6.2, 95% CI 2.1–505.5) but not advanced HIV disease was associated
with an increased risk of postpartum morbidity. Conclusion. Cesarean delivery and not advanced HIV disease increases the risk of
postpartum morbidity in women with AIDS.
Copyright © 2006 Judette Louis et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Womenaremakingupanincreasingpartoftheacquiredim-
mune deﬁciency syndrome (AIDS) epidemic in the United
States [1]. In 2001 HIV infection was the 6th leading cause of
death among all women aged 25–34 years and the 4th lead-
ing cause of death among all women aged 35–44 years. By
the end of 2003, women and adolescents represented 22% of
the people living with AIDS [1]. With the considerable num-
ber of women of childbearing age with AIDS, issues related
to pregnancy remain a concern. Initial studies in the ﬁeld of
perinatal HIV focused on vertical transmission. As we have
madegreatstridestoreduceverticaltransmissiontolessthan
2% in the US, there has been an increased focus on maternal
health.
While childbirth in developed countries is relatively safe,
there exists a risk of morbidity. Of signiﬁcance, cesarean sec-
tion is associated with an increased risk and, in particu-
lar, infectious morbidity [2]. Risk factors for morbidity in-
clude prolonged rupture of membranes, obesity, immune
suppression, and type of anesthesia, nonelective cesarean de-
livery, and a number of vaginal examinations among oth-
ers [3]. Women with AIDS are severely immunocompro-
mised and may be at increased risk for postpartum morbid-
ity. While studies have indicated that the risk may be greater
for HIV-infected patients, few studies have estimated the
risk among the most immunocompromised of these patients
[4]. Further more, no studies have examined the diﬀerence
in postpartum management. This study sought to estimate
the risk of postpartum morbidity among patients with AIDS
comparedtomoreimmunocompetentHIV-infectedpatients
and HIV-uninfected women. An additional objective was to
determine the impact of their diagnosis on the management
of puerperal infections.
SUBJECTS AND METHODS
This retrospective chart review was approved by the In-
stitutional Review Board at Wayne State University. All of
the patients delivered at a single urban tertiary care center.
Cases consisted of patients with a diagnosis of HIV infec-
tion who delivered from January 1, 2000–June 1, 2005. Un-
infected controls were selected utilizing a computerized peri-
natal database and random number allocation. Charts with
incomplete medical records or undocumented HIV testing
during the current pregnancy were excluded. Medical charts
were reviewed for demographic data, clinical characteris-
tics, antenatal course, delivery data, and postpartum man-
agement. Among HIV-infected patients, treatment data were
recorded including CD4 cell count, HIV-1 RNA viral load
measurements, and use of highly active antiretroviral ther-
apy (HAART). Group 1 consisted of patients diagnosed with
AIDS as deﬁned by a current or prior history of a CD4 cell
count< 200cells/µLoranopportunisticinfection[5].Group2 Infectious Diseases in Obstetrics and Gynecology
Table 1: Demographic data by group.†
Group 1 (AIDS) Group 2 (HIV infected) Group 3 (HIV uninfected) P-value∗
N = 33 N = 115 N = 152
Black 27(81.8) 102(89.5) 128(84.2) .36
Caucasian 2(6.1) 8(7.0) 12(7.9) .92
Hispanic 4(12.1) 2(1.8) 12(7.9) .03
Insurance government 24(72.7) 73(65.2) 128(84.2) .002
Tobacco 8(24.2) 33(28.9) 24(15.8) .03
Drug use 11(33.3) 28(24.6) 8(5.3) <. 0001
Age (years) 28(24–32) 28(23–35) 24(19–28) <. 0001
BMI (kg/m2) 27(22–32) 27(24–35) 32(28–37) <. 0001
Adherent antiretroviral use 28(84.8) 93(80.9) — N/A
Predelivery CD4 (cells/mm3) 185(108–310) 534(420–720) — N/A
†Data presented as N (%) or median (interquartile range).
∗Represents comparison across groups.
2consistedofrelativelyimmunocompetentHIV-infectedpa-
tients (CD4 ≥ 200 cells/µL) and Group 3 consisted of HIV-
uninfected patients. Febrile morbidity was deﬁned as a tem-
perature ≥ 38.0◦C 24 hours or greater postdelivery. Postpar-
tum endometritis was deﬁned as persistently elevated tem-
perature with uterine tenderness in the absence of evidence
of a nonuterine etiology. Postpartum morbidity was deﬁned
as anemia requiring a blood transfusion, endometritis, other
infectious morbidity, wound complication, repeat admission
for a pregnancy-related complication within 6 weeks postde-
livery, or unexpected surgery. Infectious morbidity was de-
ﬁned as the presence of endometritis, wound infection, or
pneumonia. Data regarding the indication for use of intra-
venousantibiotics,theuseofimaginginassessmentoffebrile
morbidity, and the time from the ﬁrst fever until initiation of
intravenous (IV) antibiotics were collected as well. Postdeliv-
erylengthofstay(LOS)wasdeﬁnedasthetimefromdelivery
until discharge from the hospital.
STATISTICAL ANALYSIS
Statistical analysis was performed utilizing the SPSS statisti-
c a ls o f t w a r e( v e r s i o n1 4 .0S P S SI n c ,C h i c a g o ,I L ) .W i l c o x o n
ranks sum test and the Kruskal-Wallis test were utilized for
discrete and continuous variables. The chi square test was
utilized for binomial variables. A logistic regression was per-
formed to evaluate possible confounders. Postpartum mor-
bidity was the outcome of interest. The variables included
were government insurance, age, body mass index (BMI),
nulliparity, drug abuse history, smoking, cesarean section af-
ter labor, intrapartum fever, general anesthesia, duration of
membrane rupture, and cesarean delivery. A probability of
P<. 05 was signiﬁcant.
RESULTS
There were 148 HIV-infected patients with complete data.
Of that group, 33 were diagnosed with AIDS by CDC cri-
teria and 7 of those women had symptomatic AIDS. The
uninfected control group consisted of 152 HIV-uninfected
women.Table 1 consistsofdemographicdatabygroup.HIV-
infected women were more likely to smoke (24.2a n d2 8 .9
versus 15.8%, P = .03), have a drug abuse history (33.3a n d
24.6v e r s u s5 .3%, P<. 0001), were older (median 28 and 28
versus 24 years, P<. 0001), and had a lower BMI (median
27 and 27 versus 32kg/m2, P<. 0001). Overall, 82% of the
HIV-infected women were adherent with their antretroviral
therapy. Clinical data are presented in Table 2.W o m e nw i t h
AIDS were more likely to have a cesarean delivery (59.4v e r -
sus 35.1a n d1 5 .8%, P<. 0001) and there was no diﬀerence
in the use of prophylactic antibiotics at the time of cesarean
section. Among women with a vaginal delivery, patients with
AIDS had a shorter duration of rupture of membranes (me-
dian 50 minutes versus 63 and 193 minutes, P<. 0001) but
there was no diﬀerence in the number of vaginal exams or
the duration of labor. Women with AIDS were more likely to
have a postpartum morbidity (32.3v e r s u s1 9 .3a n d1 3 .2%,
P = .03) or an infectious morbidity (22.6v e r s u s1 1 .54 and
5.3%, P = .007). The highest rate of infectious morbidity
was among women with symptomatic AIDS (66%). There
was no diﬀerence in febrile morbidity, hemorrhage, wound
complications, and multiple complications among the three
groups. Women with AIDS were more likely to have radio-
logical imaging in the evaluation of febrile morbidity and a
resultant delay in initiation of IV antibiotics but there was
no diﬀerence in the rate of antibiotic use (Table 3). Among
the imaging modalities, chest radiography was performed in
13 of the 19 patients who had imaging. One demonstrated
pneumoniaandtherestwerenegative.Abdominalandpelvic
computed axial tomography was performed in 4 of the 19
of the patients, yielding the diagnosis of a pelvic abscess in
one patient and a small bowel obstruction in another. Two
patients had a head and neck magnetic resonance imaging
(MRI); one demonstrated lesions suggestive of cryptococcal
meningitis. In a logistic regression controlling for potential
confounders, cesarean delivery (OR 19.5, 95% CI 5.4–69.8)
and not advanced HIV disease were associated with an in-
creased risk of postpartum morbidity (see Table 4).Judette Louis et al 3
Table 2: Clinical data by group.†
Group 1 (AIDS) Group 2 (HIV infected) Group 3 (HIV uninfected) P-value∗
N = 33 N = 115 N = 152
Cesarean section 19(59.4) 40(35.1) 24(15.8) <. 0001
Elective 15(46.9) 23(20.2) 4(2.7) <. 0001
Emergent 3(9.4) 9(7.9) 8(5.3) .57
General anesthesia 1(3.7) 6(5.4) 1(.7) .06
Duration of labor (hours)∗∗ 6(3–8) 9.5(6–13) 8.3(5.6–11) .07
Duration of membrane 50 (5.5–390.5) 63(9–171.5) 192 (96–441.5) <. 0001
rupture (minutes)∗∗
Vaginal exams∗∗ 3(3–6) 4(3–6) 4(3–5) .07
Febrile morbidity 6(18.8) 15(13.2) 24(15.8) .70
Any complication 10(32.3) 22(19.3) 20(13.2) .03
Multiple complications 3(9.7) 7(6.1) 4(2.6) .16
Infectious morbidity 7(22.6) 13(11.5) 8(5.3) .007
Wound complication 1(3.2) 6(5.3) 8(5.3) .89
Hemorrhage 0 2(1.8) 8(5.3) .16
†Data presented as N (%) or median (interquartile range).
∗Represents comparison across groups.
∗∗Among women with vaginal delivery.
Table 3: Management of febrile morbidity.†
Group 1 Group 2 Group 3 P-value∗
Duration of fever (d) 3(1–6) 3(1–4) 2(1–4) .54
Imaging 6(18.8) 9(7.9) 4(2.6) .001
IV antibiotics 5(83.3) 12(80.0) 16(66.7) .54
Time to ABX initiation (h) 9 (3–27) 7(1–57) 1(1–8) .015
LOS (d) 6(2–8) 4(3–5) 4(2–5) .39
†Data presented as N (%) or median (interquartile range).
∗Represents comparison across groups.
Table 4: Logistic regression modeling for risk factors for postpar-
tum morbidity.
Odds ratio 95.0% CI
Group 1 .66 .14–3.1
Group 2 .673 .19–2.4
Government insured 1.214 .36–4.1
Age .959 .864–1.1
Nulliparous 1.161 .34–3.9
BMI .984 .9–1.04
Drug abuse history .640 .14–2.9
Smoking 1.647 .5–5.3
Cesarean after labor .686 .1–4.7
Intrapartum fever .087 .009–.84
Duration of rupture of membranes 1.002 1.0–1.004
Cesarean delivery 19.486 5.4–69.8
DISCUSSION
We found an association between advanced HIV disease and
postpartum morbidity. In particular, infectious morbidity
was diagnosed more frequently in women with advanced
HIV disease than in relatively immunocompetent HIV-
infected women and in HIV-uninfected women. When con-
trolling for potential confounders, the majority of the risk
appearedtobeassociatedwithcesareandeliveryandnotHIV
immune status. Additionally, in the management of postpar-
tum febrile morbidity, there was an increased use of imaging
and a delay in initiation of antibiotics among women with
AIDS.
Our ﬁnding is similar to a previously published study
by Marcollet et al. In a retrospective review of 401 HIV-
infected women, Marcollet et al found that women with
AIDS were more likely to have febrile morbidity but there
was no diﬀerence in postpartum complications [6]. In that
study, the predominant risk was associated with cesarean
delivery. Watts et al in a study of 497 women participat-
ing in the Pediatric Aids Clinical Trial Group study of
HIV-infected women with a CD4 count below 500 cells/µL
demonstratedanincreasedriskofpostpartummorbiditybut
that risk was associated with cesarean delivery [7]. Other
studies that estimated risk focused only on patients under-
going cesarean delivery. In those studies, risk appeared to4 Infectious Diseases in Obstetrics and Gynecology
be associated with the degree of immune suppression. Sem-
prini et al in a study of 156 HIV-infected women under-
going cesarean delivery and controlling for potential con-
founding variables demonstrated that profound immunode-
ﬁciency (deﬁned as a CD4 count below 200 cells/µL) was the
predominant risk factor for postpartum morbidity [8]. Sim-
ilarly, Maiques-Montesinos et al in a case control study of
HIV-infected women undergoing cesarean section demon-
strated that the lowest risk of morbidity was among HIV-
infected women with a CD4 count > 500 cells/µLc o m p a r e d
tomoreimmunosuppressedpatients[9].Theobviousincon-
sistencies in the ﬁndings among the diﬀerent studies cited
may be related to diﬀerences in sample size and patient pop-
ulation.
In our study, we found an increased use of imaging in
theevaluationoffebrilemorbidityamongwomenwithAIDS
andaresultantdelayininitiationofantibiotics.Therewasno
diﬀerence in the overall use of IV antibiotics. The manage-
ment of febrile morbidity among these immunosuppressed
women is a question that has yet to be answered. In the
uninfected population, prophylactic antibiotics have been
demonstratedtodecreaseperioperativemorbidity associated
with cesarean delivery [2, 10]. Longer duration of antimicro-
bial therapy has not been advocated. However, those studies
did not include the evaluation of HIV-infected women. Our
data indicate that interventions for decreasing postcesarean
infectious morbidity in women with AIDS warrant investi-
gation.
Inourcohort,thepredominantindicationforelectivece-
sarean delivery was a high viral load (data not shown). In a
randomized trial, the European Mode of Delivery Collabora-
tive demonstrated a 50% reduction of vertical transmission
with the use of scheduled cesarean section [11]. This ﬁnd-
ing was conﬁrmed by a large meta-analysis [12]. The ﬁnd-
ings of these studies resulted in the release of a committee
opinion by the American College of Obstetricians and Gy-
necologists, which indicated that patients with a viral load
> 1000 copies/ml should be counseled and oﬀered an elec-
tive cesarean section at 38 weeks of gestation to decrease the
risk of vertical transmission [13]. Since that time, the use of
cesarean section as a tool in the prevention of maternal-to-
child transmission has increased [14]. While this has been an
eﬀective part of the management to decrease perinatal trans-
mission, it does so at a maternal cost. Among high-risk pa-
tients who may present late for prenatal care, prompt diag-
nosis and initiation of highly active retroviral treatment play
a crucial role. In particular, women with advanced HIV in-
fection may have a higher baseline viral load or therapeu-
tic resistance requiring therapy manipulation [15]. Eﬀective
therapy may decrease the number of women requiring a ce-
sarean delivery thus decreasing the associated perioperative
morbidity.
This study is limited in that it is a retrospective review
at a single institution. The patient population was partic-
ularly in high risk with regards to entry to care and sub-
stance abuse. Providers were not blinded in regards to im-
mune status. As such, that information may have impacted
their management decisions. Additionally, the small-sample
sizes may preclude us from detecting an association that may
truly exist. Regardless, this study illustrates that women with
AIDSfaceadditional risks withcesareandelivery.Theseﬁnd-
ings would confer an additional duty for the perinatal care
provider to include more information about these risks in
the extensive counseling given to women with AIDS when
planning for mode of delivery prior to initiation of labor.
Theseﬁndingsemphasizefurthertheimportanceofearlyini-
tiation of prenatal care to allow time for viral load suppres-
sionandplaceHIVcareprovidersforwomenofchildbearing
age at the leading edge of this most important care initia-
tive.
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